» Articles » PMID: 30964652

Monitoring of Microphysiological Systems: Integrating Sensors and Real-Time Data Analysis Toward Autonomous Decision-Making

Overview
Journal ACS Sens
Specialty Biotechnology
Date 2019 Apr 10
PMID 30964652
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Microphysiological systems replicate human organ function and are promising technologies for discovery of translatable biomarkers, pharmaceuticals, and regenerative therapies. Because microphysiological systems require complex microscale anatomical structures and heterogeneous cell populations, a major challenge remains to manufacture and operate these products with reproducible and standardized function. In this Perspective, three stages of microphysiological system monitoring, including process, development, and function, are assessed. The unique features and remaining technical challenges for the required sensors are discussed. Monitoring of microphysiological systems requires nondestructive, continuous biosensors and imaging techniques. With such tools, the extent of cellular and tissue development, as well as function, can be autonomously determined and optimized by correlating physical and chemical sensor outputs with markers of physiological performance. Ultimately, data fusion and analyses across process, development, and function monitors can be implemented to adopt microphysiological systems for broad research and commercial applications.

Citing Articles

Continuous Biosensor Based on Particle Motion: How Does the Concentration Measurement Precision Depend on Time Scale?.

Lubken R, Lin Y, Haenen S, Bergkamp M, Yan J, Nommensen P ACS Sens. 2024; 9(9):4924-4933.

PMID: 39166946 PMC: 11443519. DOI: 10.1021/acssensors.4c01586.


Multi-cellular engineered living systems to assess reproductive toxicology.

Lopez I, Truskey G Reprod Toxicol. 2024; 127:108609.

PMID: 38759876 PMC: 11179964. DOI: 10.1016/j.reprotox.2024.108609.


Humanized brain organoids-on-chip integrated with sensors for screening neuronal activity and neurotoxicity.

Saglam-Metiner P, Yildirim E, Dincer C, Basak O, Yesil-Celiktas O Mikrochim Acta. 2024; 191(1):71.

PMID: 38168828 DOI: 10.1007/s00604-023-06165-4.


Innovative electrode and chip designs for transendothelial electrical resistance measurements in organs-on-chips.

Holzreuter M, Segerink L Lab Chip. 2024; 24(5):1121-1134.

PMID: 38165817 PMC: 10898416. DOI: 10.1039/d3lc00901g.


Organ-on-a-chip meets artificial intelligence in drug evaluation.

Deng S, Li C, Cao J, Cui Z, Du J, Fu Z Theranostics. 2023; 13(13):4526-4558.

PMID: 37649608 PMC: 10465229. DOI: 10.7150/thno.87266.


References
1.
Stoll T, Pugeaud P, von Stockar U, Marison I . A simple HPLC technique for accurate monitoring of mammalian cell metabolism. Cytotechnology. 1994; 14(2):123-8. DOI: 10.1007/BF00758177. View

2.
Pemberton R, Cox T, Tuffin R, Drago G, Griffiths J, Pittson R . Fabrication and evaluation of a micro(bio)sensor array chip for multiple parallel measurements of important cell biomarkers. Sensors (Basel). 2014; 14(11):20519-32. PMC: 4279497. DOI: 10.3390/s141120519. View

3.
Liu H, MacQueen L, Usprech J, Maleki H, Sider K, Doyle M . Microdevice arrays with strain sensors for 3D mechanical stimulation and monitoring of engineered tissues. Biomaterials. 2018; 172:30-40. DOI: 10.1016/j.biomaterials.2018.04.041. View

4.
Kim C, Kasuya J, Jeon J, Chung S, Kamm R . A quantitative microfluidic angiogenesis screen for studying anti-angiogenic therapeutic drugs. Lab Chip. 2014; 15(1):301-10. PMC: 4311754. DOI: 10.1039/c4lc00866a. View

5.
Lewis A, Abu-Absi N, Borys M, Li Z . The use of 'Omics technology to rationally improve industrial mammalian cell line performance. Biotechnol Bioeng. 2015; 113(1):26-38. DOI: 10.1002/bit.25673. View